Hydroprotopine

CAS No. 128397-41-1

Hydroprotopine( —— )

Catalog No. M17921 CAS No. 128397-41-1

Hydroprotopine, treatment for coronary heart disease and angina, and the treatment effect is remarkable.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 67 In Stock
5MG 60 In Stock
10MG 86 In Stock
25MG 140 In Stock
50MG 200 In Stock
100MG 296 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Hydroprotopine
  • Note
    Research use only, not for human use.
  • Brief Description
    Hydroprotopine, treatment for coronary heart disease and angina, and the treatment effect is remarkable.
  • Description
    Hydroprotopine, treatment for coronary heart disease and angina, and the treatment effect is remarkable.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Transferase
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    128397-41-1
  • Formula Weight
    354.38
  • Molecular Formula
    C20H20NO5+
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[N+]12CCC3=CC4=C(C=C3C1(CC5=C(C2)C6=C(C=C5)OCO6)O)OCO4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Ervogastat

    Ervogastat is a potent and well-tolerated diacylglycerol acyltransferase 2 inhibitor.

  • Opicapone

    Opicapone reduces the ATP content of the cells (IC50: 98 μM).

  • Pradigastat

    Pradigastat (LCQ-908) is an orally active, potent and selective diacylglycerol acyltransferase 1 (DGAT1) inhibitor for the treatment of constipation, which may be used in the study of obesity and diabetes.